Introduction
The incidence of cancer of the gastric remnant has steadily increased [1] [2] [3] [4] [5] , and this increase may be related to the high frequency of gastrectomies performed 20 to 30 years ago. Many reports have studied the pathogenesis and causes of gastric remnant cancer [5] [6] [7] [8] [9] [10] , but there is little information available on molecular biological analyses to identify individuals susceptible to gastric remnant cancer.
A subset of gastrointestinal cancers harbors numerous genetic alterations which are often found in simple troduodenostomies. The patients consisted of seven men and two women. The mean age of the patients at the time of diagnosis of gastric remnant cancer was 67.2 years (range, 55 to 48 years). The mean time between the primary gastric resection and the occurrence of gastric remnant cancer was 30.4 Ϯ 4.9 years (range, 20 to 42 years) for the patients with primary gastroduodenal ulcer and 12.5 Ϯ 5.0 years (range, 5 to 22 years) for those with primary gastric cancer.
Ten patients with primary gastric cancer of the upper third of the stomach who underwent a radical gastric resection in the same period served as a control group. They consisted of nine men and one woman, with a mean age of 65.2 Ϯ 7.9 years (range, 38 to 78 years). No patients had a family history of HNPCC. Table 1 shows the tumor characteristics (depth of invasion and tumor stage) of the gastric remnant cancer and cancer in the controls. There were no differences in the tumor characteristics between the two groups. The histologic type of cancer also showed no differences between the two groups.
Cancers and corresponding normal tissues were fixed with formalin and embedded in paraffin. Using a hematoxylin-eosin-stained section as a guide, we microscopically dissected serial 8-µm sections from these samples to separate the tumor from normal tissues. DNA was extracted from the regions that contained at least 80% of tumor cells or normal cells. Genomic DNA was extracted by the standard proteinase K and phenolchloroform methods.
Microsatellite analysis
We used oligonucleotide primer sets for the six microsatellite loci containing cytosine-adenine dinucleotide repeats to observe any replication errors (RER); D1S213, D8S135, D10S197, D17S518, D17S807, and D18S34. Genomic DNA (50 to 100 ng) was used as a template for polymerase chain reaction (PCR) amplication in 50-µl reaction volumes. Amplification was performed by the hot start method, using Taq polymerase (TaKaRa Taq; TaKaRa, Kyoto, Japan) and Taq start antibody (Clontech Laboratories, Palo Alto, CA, USA) in a DNA thermal cycler (Perkin-Elmer, Foster City, CA, USA), using 35 amplification cycles, consisting of 1 min at 94°C, 1 min at 56°C, and 1 min at 72°C. The PCR buffer included final concentrations of 10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl 2 , 50 mM KCl, and each dNTP at 250 µM.
The PCR products and denaturing stop solution (95% formamide, 10 mM ethylenediamiretetraacetic acid [EDTA], 0.25% bromophenolblue, and xylene cyanol FF) were heated at 95°C for 5 min and then rapidly cooled on ice. Electrophoresis was carried out on 10% polyacrylamide gels at 200 V for 6 h, and the gels were stained with silver (Silver Stain Kit; Daiichi Pure Chemicals, Tokyo, Japan).
For the detection of MSI, the PCR products of tumor and normal DNA from the same patients were run in adjacent lines, and the patterns were compared. MSI was defined as positive when the tumor DNA displayed Ia  4  1  II  0  0  IIIa  1  3  IIIb  0  2  IVa  0  3  IVb  4  1 m, Muscosa; sm, submucosa; mp, muscularis propria; ss subserosa; se (serosa-exposed), tumor invasion observed on the serosal surface and the peritoneal cavity; si (serosa-infiltrating), tumor invasion observed in adjacent structures a The stage was classified according to the Japanese Classification of Gastric Carcinoma fragment sizes not present in normal DNA. The PCR products were purified using the QIA-quick spin PCR purification kit (Qiagen, Chatsworth, CA, USA) and then directly sequenced (TaKaRa), using the endlabeled primers and kit protocols of the manufacturer.
Statistical analysis
The 2 test was used to determine significance regarding the microsatellite instability data. Figure 1 shows the typical polyacrylamide gel findings of gastric DNA amplified by PCR. The MSI data are summarized in Table 2 .
Results
In the gastric remnant cancer samples (patients 1-9), eight of the nine patients (88.9%) showed MSI at one locus. In one of them (11.1%), MSI was detected at two loci. This patient had undergone gastrectomy for the primary gastric cancer. When analyzed by the type of reconstruction, MSI was detected in four of the five patients with gastroduodenostomy and in four of the four patients with gastrojejunostomy. The time between the primary gastric resection and the occurrence of gastric remnant cancer was not significantly different between patients with MSI-positive cancer (22.7 years) and those with MSI-negative cancer (22 years).
In the control group (patients 10-19), two of the ten cancers (20%) were found to be unstable. Both showed MSI at two loci. The histologic type of cancer and MSI were not related in either group.
The difference in MSI frequency between the gastric remnant cancer and control groups was highly significant (P Ͻ 0.01) ( Table 3) .
Discussion
In this study, the frequency of MSI was investigated in nine gastric remnant cancers. It was found that eight of these cancers (88.9%) showed MSI. In the control group of patients who had only one cancer in the upper third of the stomach, MSI occurred in only two of the ten patients (20%). In studies concerning MSI in gastric cancer, the incidence of MSI-positive cancers ranged from 15% to 39% [13, [16] [17] [18] [19] . In this study, the difference in the frequency of MSI between cancers from the gastric remnant group and those from the control group was significant. This finding suggests that gastric remnant cancer may be rare, but that patients with a remnant stomach tend to develop metachronous gastric cancer more often than patients with sporadic gastric cancer in the upper third of the stomach.
As for MSI, there are two problems regarding its definition [19] : (1) How many altered microsatellite loci are required for the condition to be classified as MSI? Table 2 . Microsatellite instability in the gastric remnant group (patients 1-9) and control group (patients [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Microsatellite loci Patient number D1S213 D17S518 D18S34 D17S807 D8S135 D10S197
and (2) how many microsatellite loci, and which loci, should be examined to determined MSI? Unfortunately these two problems have not yet been resolved. In accordance with most studies that examined MSI [13, [16] [17] [18] [19] , one or more altered microsatellite loci were classified as MSI; we examined six microsatellite loci in Table 3 . Microsatellite instability in the gastric remnant group and control group One locus (ϩ) Two loci (ϩ) Total
Gastric remnant group (n ϭ 9) 7/9 (77.7) 1/9 (11.1) 8/9 (88.9) Control group (n ϭ 10) 0/10 (0.0) 2/10 (20) 2/10 (20) The difference in the frequency of MSI between the gastric remnant group and the control group is significant (P Ͻ 0.01) The values in parentheses are percentages this study. As the definition of MSI has not been standardized among researchers, a new proposal for the criteria of MSI is thus expected. The pathogenic factors responsible for the transformation of the mucosa in the remnant stomach to dysplasia and cancer remain unclear. They are multiple and include hereditary factors, infection with Helicobacter pylori, the action of carcinogenic N-nitroso compounds, and continued reflux injury [5] ; these factors are considered to induce atrophic gastritis, intestinal metaplasia, and dysplasia. Dysplasia, especially high-grade dysplasia, in a given patient may not only be a marker of a heightened cancer risk but may itself already be associated with early cancer elsewhere. In addition, it is also important to clarify the mechanism of this carcinogenesis to assist in the diagnosis and treatment. However, whether or not DNA instability contributes to an accumulation of genetic alterations of known multiple tumor-suppressor genes and oncogenes still remains to be elucidated.
In sporadic colorectal cancer, the frequency of MSI (RER)-positive tumors was 3% in adenoma and mucosal carcinoma [20] . It increased in invasive carcinoma and then showed a marked increase in carcinoma which metastasized to the liver. These studies suggest that DNA instability may contribute to additional alterations necessary for the progression of tumors to a highly malignant stage, such as metastasis [21] . Similarly, an abnormal nuclear DNA content, cell cycle abnormalities, or a high expression of oncogenes or tumor-suppressor genes are common in dysplasia and cancer of the stomach [5, 22, 23] . These findings indicate that the gastric mucosa, including the remnant mucosa, is prone to genomic instability, and some of these patients with genomic instability develop cancer. In oncogene studies, some genes may thus be a helpful marker for identifying dysplastic lesions that tend to progress to cancer. However, the potential clinical utility of specific oncogenes in predicting a heightened cancer risk remains to be clarified.
In conclusion, this study demonstrated that MSI is a common feature of cancers in patients who develop gastric remnant cancer. It was detected in 88.9% of gastric remnant cancers in these patients. These findings suggest that the presence of one or more MSI shows deviation from the normal pattern [16] is associated with remnant gastric cancer after gastrectomy.
